Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Ischemic Heart Disease

  Free Subscription

Articles published in Heart

Retrieve available abstracts of 72 articles:
HTML format

Single Articles

    November 2021
  1. RAQABANI MA, Musa AM, Al-Assaf OY
    ST elevation in a critically ill patient with COVID-19: what is the emergency treatment?
    Heart. 2021;107:1703-1764.

    October 2021
  2. DE LUCA G, Algowhary M, Uguz B, Oliveira DC, et al
    COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction.
    Heart. 2021 Oct 28. pii: heartjnl-2021-319750. doi: 10.1136/heartjnl-2021-319750
    PubMed     Abstract available

  3. ASLEH R
    Persistent sex differences in outcomes after coronary heart disease: time to move from observation to action.
    Heart. 2021 Oct 19. pii: heartjnl-2021-320031. doi: 10.1136/heartjnl-2021-320031

  4. DE ABAJO FJ, Rodriguez-Martin S, Barreira D, Rodriguez-Miguel A, et al
    Influenza vaccine and risk of acute myocardial infarction in a population-based case-control study.
    Heart. 2021 Oct 13. pii: heartjnl-2021-319754. doi: 10.1136/heartjnl-2021-319754
    PubMed     Abstract available

    September 2021
  5. COELHO-LIMA J, Georgiopoulos G, Ahmed J, Adil SER, et al
    Prognostic value of admission high-sensitivity troponin in patients with ST-elevation myocardial infarction.
    Heart. 2021 Sep 20. pii: heartjnl-2021-319225. doi: 10.1136/heartjnl-2021-319225
    PubMed     Abstract available

  6. MCLEOD P, Adamson PD, Coffey S
    Do we need early risk stratification after ST-elevation myocardial infarction?
    Heart. 2021 Sep 20. pii: heartjnl-2021-320030. doi: 10.1136/heartjnl-2021-320030

  7. LIU Y, Tan N, Huo Y, Chen S, et al
    Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial.
    Heart. 2021 Sep 11. pii: heartjnl-2021-319716. doi: 10.1136/heartjnl-2021-319716
    PubMed     Abstract available

  8. LOWRY MTH, Anand A, Mills NL
    Implementing an early rule-out pathway for acute myocardial infarction in clinical practice.
    Heart. 2021 Sep 3. pii: heartjnl-2019-316242. doi: 10.1136/heartjnl-2019-316242.

    August 2021
  9. AKYEA RK, Kontopantelis E, Kai J, Weng SF, et al
    Sex disparity in subsequent outcomes in survivors of coronary heart disease.
    Heart. 2021 Aug 24. pii: heartjnl-2021-319566. doi: 10.1136/heartjnl-2021-319566
    PubMed     Abstract available

  10. BAINEY KR, Zheng Y, Coulden R, Sonnex E, et al
    Remote ischaemic conditioning in ST elevation myocardial infarction: a registry-based randomised trial.
    Heart. 2021 Aug 20. pii: heartjnl-2021-319455. doi: 10.1136/heartjnl-2021-319455
    PubMed     Abstract available

    July 2021
  11. MASSERA D, Hu M, Delaney JA, Bartz TM, et al
    Adverse cardiac mechanics and incident coronary heart disease in the Cardiovascular Health Study.
    Heart. 2021 Jul 13. pii: heartjnl-2021-319296. doi: 10.1136/heartjnl-2021-319296
    PubMed     Abstract available

    June 2021
  12. PHREANER N, Daniels LB
    Sex differences in type 2 myocardial infarction: learning that we still have a lot to learn.
    Heart. 2021 Jun 30. pii: heartjnl-2021-319432. doi: 10.1136/heartjnl-2021-319432

    May 2021
  13. CADER FA, Yancy CW, Banerjee S
    To be, or not to be BAME, in the time of COVID-19: does it matter?
    Heart. 2021;107:692-693.

    April 2021
  14. KIMENAI DM, Lindahl B, Chapman AR, Baron T, et al
    Sex differences in investigations and outcomes among patients with type 2 myocardial infarction.
    Heart. 2021 Apr 20. pii: heartjnl-2021-319118. doi: 10.1136/heartjnl-2021-319118
    PubMed     Abstract available

  15. MCGOVERN L, Cosgrave J
    Axial flow ventricular assist devices in cardiogenic shock complicating acute myocardial infarction.
    Heart. 2021 Apr 2. pii: heartjnl-2020-318226. doi: 10.1136/heartjnl-2020-318226.
    PubMed     Abstract available

  16. ZHANG KW
    Out of the woods, but still in the weeds: When cancer therapy becomes part of a chronic condition.
    Heart. 2021;107:607-608.

    March 2021
    Ticagrelor versus prasugrel for PCI-managed myocardial infarction: the battle of the giants continues.
    Heart. 2021 Mar 19. pii: heartjnl-2020-318872. doi: 10.1136/heartjnl-2020-318872

  18. VENETSANOS D, Traff E, Erlinge D, Hagstrom E, et al
    Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention.
    Heart. 2021 Mar 12. pii: heartjnl-2020-318694. doi: 10.1136/heartjnl-2020-318694
    PubMed     Abstract available

  19. RASHID M, Timmis A, Kinnaird T, Curzen N, et al
    Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic.
    Heart. 2021 Mar 8. pii: heartjnl-2020-318356. doi: 10.1136/heartjnl-2020-318356.
    PubMed     Abstract available

  20. SIMON T, Danchin N
    Beware of simple explanations.
    Heart. 2021;107:348-349.

  21. KUMAR R, Bhasin D, Isser HS
    Typical chest pain and an ominous ECG.
    Heart. 2021;107:380-432.

    February 2021
  22. DANCHIN N, Marijon E
    COVID-19 pandemic: preventing hospital myocardial infarction admissions or preventing acute myocardial infarction altogether?
    Heart. 2021 Feb 1. pii: heartjnl-2020-318646. doi: 10.1136/heartjnl-2020-318646.

    January 2021
  23. BOSSARD M, Gao P, Boden W, Steg G, et al
    Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease.
    Heart. 2021 Jan 27. pii: heartjnl-2020-318045. doi: 10.1136/heartjnl-2020-318045
    PubMed     Abstract available

  24. GIANNOPOULOS G, Karageorgiou S, Vrachatis D, Anagnostopoulos I, et al
    A stand-alone structured educational programme after myocardial infarction: a randomised study.
    Heart. 2021 Jan 22. pii: heartjnl-2020-318414. doi: 10.1136/heartjnl-2020-318414
    PubMed     Abstract available

  25. WU J, Hall AS, Gale CP
    Long-term survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure.
    Heart. 2021 Jan 15. pii: heartjnl-2020-316823. doi: 10.1136/heartjnl-2020-316823
    PubMed     Abstract available

  26. RYAN M, Morgan H, Petrie MC, Perera D, et al
    Coronary revascularisation in patients with ischaemic cardiomyopathy.
    Heart. 2021 Jan 12. pii: heartjnl-2020-316856. doi: 10.1136/heartjnl-2020-316856
    PubMed     Abstract available

  27. YANDRAPALLI S, Malik A, Pemmasani G, Aronow W, et al
    Sex differences in heart failure hospitalisation risk following acute myocardial infarction.
    Heart. 2021 Jan 11. pii: heartjnl-2020-318306. doi: 10.1136/heartjnl-2020-318306
    PubMed     Abstract available

  28. WU J, Mamas MA, Mohamed MO, Kwok CS, et al
    Place and causes of acute cardiovascular mortality during the COVID-19 pandemic.
    Heart. 2021;107:113-119.
    PubMed     Abstract available

  29. KOK WE
    Too often and too early: the risk of cardiac ischaemia in adult survivors of childhood cancer.
    Heart. 2021;107:6-7.

  30. ONISHI T, Nakano Y, Hirano KI, Nagasawa Y, et al
    Prevalence and clinical outcomes of triglyceride deposit cardiomyovasculopathy among haemodialysis patients.
    Heart. 2021;107:127-134.
    PubMed     Abstract available

  31. FEIJEN EAM, van Dalen EC, van der Pal HJH, Reulen RC, et al
    Increased risk of cardiac ischaemia in a pan-European cohort of 36 205 childhood cancer survivors: a PanCareSurFup study.
    Heart. 2021;107:33-40.
    PubMed     Abstract available

  32. JOLICOEUR EM, Verheye S, Henry TD, Joseph L, et al
    A novel method to interpret early phase trials shows how the narrowing of the coronary sinus concordantly improves symptoms, functional status and quality of life in refractory angina.
    Heart. 2021;107:41-46.
    PubMed     Abstract available

    December 2020
  33. DE FILIPPO O, D'Ascenzo F, Deferrari GM
    COVID-19 pandemic and infarctions: another call to reorganise our healthcare systems.
    Heart. 2020;106:1786-1787.

    November 2020
  34. OTTO CM
    Heartbeat: exercise improves quality of life after acute myocardial infarction.
    Heart. 2020;106:1705-1706.

    October 2020
  35. DING Q, Spatz ES, Lipska KJ, Lin H, et al
    Newly diagnosed diabetes and outcomes after acute myocardial infarction in young adults.
    Heart. 2020 Oct 20. pii: heartjnl-2020-317101. doi: 10.1136/heartjnl-2020-317101
    PubMed     Abstract available

  36. DE BACQUER D, van de Luitgaarden IAT, De Smedt D, Vynckier P, et al
    Socioeconomic characteristics of patients with coronary heart disease in relation to their cardiovascular risk profile.
    Heart. 2020 Oct 16. pii: heartjnl-2020-317549. doi: 10.1136/heartjnl-2020-317549
    PubMed     Abstract available

  37. MOHAMMAD MA, Koul S, Olivecrona GK, Gtberg M, et al
    Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic.
    Heart. 2020 Oct 6. pii: heartjnl-2020-317685. doi: 10.1136/heartjnl-2020-317685.
    PubMed     Abstract available

  38. NIJJER SS, Petraco R, Sen S
    Optimal management of acute coronary syndromes in the era of COVID-19.
    Heart. 2020;106:1609-1616.

    August 2020
  39. ZHANG X, Wang S, Liu J, Wang Y, et al
    D-dimer and the incidence of heart failure and mortality after acute myocardial infarction.
    Heart. 2020 Aug 12. pii: heartjnl-2020-316880. doi: 10.1136/heartjnl-2020-316880
    PubMed     Abstract available

    July 2020
  40. WILLIAMS C, Brown DL
    Effect of random deferral of percutaneous coronary intervention in patients with diabetes and stable ischaemic heart disease.
    Heart. 2020 Jul 21. pii: heartjnl-2019-316432. doi: 10.1136/heartjnl-2019-316432
    PubMed     Abstract available

    June 2020
  41. NAZIR MS, Mittal TK, Weir-McCall J, Nieman K, et al
    Opportunities and challenges of implementing computed tomography fractional flow reserve into clinical practice.
    Heart. 2020 Jun 19. pii: heartjnl-2019-315607. doi: 10.1136/heartjnl-2019-315607
    PubMed     Abstract available

  42. HOOLE SP, Bambrough P
    Recent advances in percutaneous coronary intervention.
    Heart. 2020 Jun 10. pii: heartjnl-2019-315707. doi: 10.1136/heartjnl-2019-315707
    PubMed     Abstract available

    The comorbid patient: does your heart sink?
    Heart. 2020;106:790.

  44. ALKHALIL M, Spence MS, Owens C
    Ischaemic changes during transcatheter aortic valve implantation.
    Heart. 2020;106:801-866.

  45. CROWE F, Zemedikun DT, Okoth K, Adderley NJ, et al
    Comorbidity phenotypes and risk of mortality in patients with ischaemic heart disease in the UK.
    Heart. 2020;106:810-816.
    PubMed     Abstract available

    May 2020
  46. KEULARDS DCJ, Fournier S, van 't Veer M, Colaiori I, et al
    Computed tomographic myocardial mass compared with invasive myocardial perfusion measurement.
    Heart. 2020 May 29. pii: heartjnl-2020-316689. doi: 10.1136/heartjnl-2020-316689
    PubMed     Abstract available

  47. VAGO H, Szabo L, Dohy Z, Czimbalmos C, et al
    Early cardiac magnetic resonance imaging in troponin-positive acute chest pain and non-obstructed coronary arteries.
    Heart. 2020 May 23. pii: heartjnl-2019-316295. doi: 10.1136/heartjnl-2019-316295
    PubMed     Abstract available

  48. AHMADVAZIR S, Pradhan J, Khattar RS, Senior R, et al
    Sex-based impact of carotid plaque in patients with chest pain undergoing stress echocardiography.
    Heart. 2020 May 22. pii: heartjnl-2019-316507. doi: 10.1136/heartjnl-2019-316507
    PubMed     Abstract available

  49. KOO CY, Aung AT, Chen Z, Kristanto W, et al
    Sleep apnoea and cardiovascular outcomes after coronary artery bypass grafting.
    Heart. 2020 May 18. pii: heartjnl-2019-316118. doi: 10.1136/heartjnl-2019-316118
    PubMed     Abstract available

    Tub bathing and heart disease.
    Heart. 2020;106:710.

  51. NEUMANN JT, Twerenbold R
    How do comorbidities influence troponin concentrations?
    Heart. 2020;106:634-635.

  52. BING R, Mitchell AJ, Newby DE
    Chest pain: when in doubt....
    Heart. 2020;106:690-706.

    April 2020
  53. ADAMSON PD, Mills NL, Newby DE, Troughton RW, et al
    Response to: 'Convalescent troponin and cardiovascular death following acute coronary syndrome' by Kawada.
    Heart. 2020;106:545-546.

  54. KAWADA T
    Convalescent troponin and cardiovascular death in patients with acute coronary syndrome.
    Heart. 2020;106:545.

    Walking the tightrope: cardiovascular risk prediction in patients after acute coronary syndrome.
    Heart. 2020;106:484-486.

  56. MEHILLI J, Presbitero P
    Coronary artery disease and acute coronary syndrome in women.
    Heart. 2020;106:487-492.
    PubMed     Abstract available

  57. POPPE KK, Doughty RN, Wells S, Wu B, et al
    Development and validation of a cardiovascular risk score for patients in the community after acute coronary syndrome.
    Heart. 2020;106:506-511.
    PubMed     Abstract available

  58. PARKINSON J, Minton J, Bouttell J, Lewsey J, et al
    Do age, period or cohort effects explain circulatory disease mortality trends, Scotland 1974-2015?
    Heart. 2020;106:584-589.
    PubMed     Abstract available

    March 2020
  59. KRISAI P, Blum S, Aeschbacher S, Beer JH, et al
    Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
    Heart. 2020 Mar 31. pii: heartjnl-2019-316314. doi: 10.1136/heartjnl-2019-316314
    PubMed     Abstract available

  60. WALD DS, Casey-Gillman O, Comer K, Mansell JS, et al
    Animation-supported consent for urgent angiography and angioplasty: a service improvement initiative.
    Heart. 2020 Mar 10. pii: heartjnl-2019-316227. doi: 10.1136/heartjnl-2019-316227
    PubMed     Abstract available

    Can we improve the appropriateness of PCI?
    Heart. 2020;106:405-406.

  62. FORD TJ, Berry C
    Angina: contemporary diagnosis and management.
    Heart. 2020;106:387-398.

  63. MOSS AJ, Jordan A, Carpenter JP
    Seventy-one-year-old man with transient left bundle branch block.
    Heart. 2020;106:386-398.

  64. CAULDWELL M, Steer PJ, von Klemperer K, Kaler M, et al
    Maternal and neonatal outcomes in women with history of coronary artery disease.
    Heart. 2020;106:380-386.
    PubMed     Abstract available

    February 2020
  65. IHDAYHID AR, Sapontis J
    The fractional flow reserve grey zone: a blueprint for the future of coronary revascularisation.
    Heart. 2020 Feb 29. pii: heartjnl-2019-316435. doi: 10.1136/heartjnl-2019-316435

  66. HENNIGAN B, Berry C, Collison D, Corcoran D, et al
    Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial.
    Heart. 2020 Feb 29. pii: heartjnl-2019-316075. doi: 10.1136/heartjnl-2019-316075
    PubMed     Abstract available

  67. LUPERCIO F, Giancaterino S, Villablanca PA, Han F, et al
    P2Y12 inhibitors with oral anticoagulation for percutaneous coronary intervention with atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2020 Feb 7. pii: heartjnl-2019-315963. doi: 10.1136/heartjnl-2019-315963.
    PubMed     Abstract available

  68. MARIATHAS M, Curzen N
    Use of troponins in clinical practice: Evidence against the use of troponins in clinical practice.
    Heart. 2020;106:251-252.

  69. COLLINSON PO, Apple F, Jaffe AS
    Use of troponins in clinical practice: Evidence in favour of use of troponins in clinical practice: Evidence in favour of use of troponins in clinical practice.
    Heart. 2020;106:253-255.

  70. LITWIN SE, Coles A, Hill CL, Alhanti B, et al
    Discordances between predicted and actual risk in obese patients with suspected cardiac ischaemia.
    Heart. 2020;106:273-279.
    PubMed     Abstract available

  71. SANTIAGO DE ARAUJO PIO C, Chaves G, Davies P, Taylor R, et al
    Cochrane corner: increasing patient utilisation of cardiac rehabilitation.
    Heart. 2020;106:248-250.

    December 2019
  72. YANG JX, Stevenson MJ, Valsdottir L, Ho K, et al
    Association between procedure appropriateness and patient-reported outcomes after percutaneous coronary intervention.
    Heart. 2019 Dec 19. pii: heartjnl-2019-315835. doi: 10.1136/heartjnl-2019-315835
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.